SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yu-Qiang Mi, Qi-Yu Shi, Liang Xu, Rui-Fang Shi, Yong-Gang Liu, Ping Li, Feng Shen, Wei Lu, Jian-Gao Fan, Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B, Digestive Diseases and Sciences, 2015, 60, 1, 243

    CrossRef

  2. 2
    Angeline Oi-Shan Lo, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Yock-Young Dan, Cost Effectiveness of Response-Guided Therapy With Peginterferon in the Treatment of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2015, 13, 2, 377

    CrossRef

  3. 3
    Jessica Howell, Caroline Van Gemert, Maud Lemoine, Mark Thursz, Margaret Hellard, An overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories, Journal of Gastroenterology and Hepatology, 2014, 29, 11
  4. 4
    Vahid Bagheri, Azam Askari, Mohammad Kazemi Arababadi, Derek Kennedy, Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?, Human Immunology, 2014, 75, 6, 549

    CrossRef

  5. 5
    Angeline Oi-Shan Lo, Grace Lai-Hung Wong, Current developments in nucleoside/nucleotide analogues for hepatitis B, Expert Review of Gastroenterology & Hepatology, 2014, 8, 6, 607

    CrossRef

  6. 6
    Mohammad Momeni, Nahid Zainodini, Reza Bidaki, Gholamhossein Hassanshahi, Hamid Daneshvar, Mehdi Khaleghinia, Maryam Ebrahim, Masoud Karimi-Googheri, Azam Askari, Mohammad Kazemi Arababadi, Derek Kennedy, Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients, Human Immunology, 2014, 75, 1, 15

    CrossRef

  7. 7
    Gholamhossein Hassanshahi, Seyyed Mohammad Ali Sajadi, Vahid Mirzaei, Ali Ravary, Hossein Khorramdelazad, Shokofe Moghadam, Nahid Zianodini, Vahid Bagheri, Mohammad Kazemi Arababadi, Expressions of ASC and caspase-1 but not AIM2 are disrupted in chronic HBV infected patients, Asian Pacific Journal of Tropical Disease, 2014, 4, 4, 301

    CrossRef

  8. 8
    Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li, Loss of HBsAg and antiviral treatment: from basics to clinical significance, Hepatology International, 2014, 8, 1, 39

    CrossRef

  9. 9
    Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun, Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B Carriers, Medicine, 2014, 93, 20, e91

    CrossRef

  10. 10
    Masoud Karimi-Googheri, Mohammad Kazemi Arababadi, TLR3 plays significant roles against hepatitis B virus, Molecular Biology Reports, 2014, 41, 5, 3279

    CrossRef

  11. 11
    A. Shahrakyvahed, J. Sanchooli, N. Sanadgol, M. K. Arababadi, D. Kennedy, TLR9: an important molecule in the fight against hepatitis B virus, Postgraduate Medical Journal, 2014, 90, 1065, 396

    CrossRef

  12. 12
    Mohammad Zare-Bidaki, Kyoko Tsukiyama-Kohara, Mohammad Kazemi Arababadi, Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis, Viral Immunology, 2014, 27, 7, 321

    CrossRef

  13. 13
    Seyyed Mohammad Ali Sajadi, Vahid Mirzaei, Gholamhossein Hassanshahi, Hossein Khorramdelazad, Hassan Yousefi Daredor, Seyyed Mohammad Hossein Hosseini, Mojgan Moogooi, Ali Ravary, Mohammad Kazemi Arababadi, Derek Kennedy, Decreased Expressions of Toll-Like Receptor 9 and Its Signaling Molecules in Chronic Hepatitis B Virus–Infected Patients, Archives of Pathology & Laboratory Medicine, 2013, 137, 11, 1674

    CrossRef

  14. 14
    Jian-Gao Fan, Epidemiology of alcoholic and nonalcoholic fatty liver disease in China, Journal of Gastroenterology and Hepatology, 2013, 28,
  15. 15
    Tao Chen, Lin Zhu, Yaoyong Zhou, Bin Pi, Xiaojuan Liu, Guohong Deng, Rong Zhang, Yuming Wang, Zeguang Wu, Meifang Han, Xiaoping Luo, Qin Ning, KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure, Clinical Immunology, 2013, 146, 3, 207

    CrossRef

  16. 16
    Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Zhuo Yu, Hoi-Yun Chan, Chi-Hang Tse, Vincent Wai-Sun Wong, Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: A prospective cohort study with paired transient elastography examination, Journal of Gastroenterology and Hepatology, 2013, 28, 11
  17. 17
    Fatemeh Ayoobi, Gholamhossein Hassanshahi, Nahid Zainodini, Hossein Khorramdelazad, Mohammad Kazemi Arababadi, Derek Kennedy, Reduced expression of TRIF in chronic HBV infected Iranian patients, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 5, 491

    CrossRef

  18. 18
    Grace Lai-Hung Wong, Who will have the best response to entecavir?, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  19. You have free access to this content19
    Hong Ma, Jidong Jia, Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue, Liver International, 2013, 33,
  20. 20
    CHANDRA JINATA, ERNAWATI ARIFIN GIRI-RACHMAN, DEBBIE SOEFIE RETNONINGRUM, Molecular Analysis of Immune-Escape Mutants of Hepatitis B Virus from Local Clinical Samples, Microbiology Indonesia, 2012, 6, 1, 9

    CrossRef

  21. 21
    G. L.-H. Wong, V. W.-S. Wong, H.-Y. Chan, P. C.-H. Tse, J. Wong, A. M.-L. Chim, K. K.-L. Yiu, S. H.-T. Chu, H. L.-Y. Chan, Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years, Alimentary Pharmacology & Therapeutics, 2012, 35, 11
  22. 22
    Hua-Jun Chen, Yu Wang, Xi-Qi Zhu, Ying Cui, Yu-Chen Chen, Gao-Jun Teng, White matter abnormalities correlate with neurocognitive performance in patients with HBV-related cirrhosis, Journal of the Neurological Sciences, 2012, 321, 1-2, 65

    CrossRef

  23. 23
    A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse, H. L.-Y. Chan, Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
  24. 24
    Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, X. Huang, R. Xie, S. Ge, J. Hu, Z. Jiang, M. Zhu, V. W.-S. Wong, H. L.-Y. Chan, Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy, Alimentary Pharmacology & Therapeutics, 2011, 34, 3
  25. 25
    Myron J. Tong, Calvin Q. Pan, Hie-Won Hann, Kris V. Kowdley, Steven-Huy B. Han, Albert D. Min, Truong-Sinh Leduc, The Management of Chronic Hepatitis B in Asian Americans, Digestive Diseases and Sciences, 2011, 56, 11, 3143

    CrossRef